Search Results - "BADRISING, U. A"

Detecting dysphagia in inclusion body myositis by Cox, F. M., Verschuuren, J. J., Verbist, B. M., Niks, E. H., Wintzen, A. R., Badrising, U. A.

“…Dysphagia is an important yet inconsistently recognized symptom of inclusion body myositis (IBM). It can be disabling and potentially life-threatening. We…”
Get full text

Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis by BADRISING, U. A, SCHREUDER, G. M. Th, GIPHART, M. J, GELEIJNS, K, VERSCHUUREN, J. J. G. M, WINTZEN, A. R

“…Whether autoimmune mechanisms play a role in the pathogenesis of inclusion body myositis (IBM) is unknown. Human leukocyte antigen (HLA) analysis in 52…”
Get full text

Epidemiology of inclusion body myositis in the Netherlands : A nationwide study by BADRISING, U. A, MAAT-SCHIEMAN, M, JENNEKENS, F, KOEHLER, P, VAN DER LEEUW, H, DE VISSER, M, VERSCHUUREN, J. J, WINTZEN, A. R, VAN DUINEN, S. G, BREEDVELD, F, VAN DOOM, P, VAN ENGELEN, B, VAN DEN HOOGEN, F, HOOGENDIJK, J, HÖWELER, C, DE JAGER, A

“…Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they are derived from larger neuromuscular centers. The present…”
Get full text

Inclusion body myositis : Clinical features and clinical course of the disease in 64 patients by BADRISING, Umesh A, MAAT-SCHIEMAN, Marion L. C, DE VISSER, Marianne, VERSCHUUREN, Jan J. G. M, WINTZEN, Axel R, VAN HOUWELINGEN, Johannes C, VAN DOORN, Pieter A, VAN DUINEN, Sjoerd G, VAN ENGELEN, Baziel G. M, FABER, Carin G, HOOGENDIJK, Jessica E, DE JAGER, Aeiko E, KOEHLER, Peter J

“…The clinical features of inclusion body myositis (IBM) were of minor importance in the design of consensus diagnostic criteria, mainly because of controversial…”
Get full text

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis by Lilleker, J B, Rietveld, A, Pye, S R, Mariampillai, K, Benveniste, O, Peeters, M T J, Miller, J A L, Hanna, M G, Machado, P M, Parton, M J, Gheorghe, K R, Badrising, U A, Lundberg, I E, Sacconi, S, Herbert, M K, McHugh, N J, Lecky, B R F, Brierley, C, Hilton-Jones, D, Lamb, J A, Roberts, M E, Cooper, R G, Saris, C G J, Pruijn, G J M, Chinoy, H, van Engelen, B G M

“…Autoantibodies directed against cytosolic 5'-nucleotidase 1A have been identified in many patients with inclusion body myositis. This retrospective study…”
Get more information

Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis by COX, Fieke M, REIJNIERSE, Monique, VAN RIJSWIJK, Carla S. P, WINTZEN, Axel R, VERSCHUUREN, Jan J, BADRISING, Umesh A

“…To analyse whether MRI of upper and lower extremity muscles in a large patient group with sporadic IBM (sIBM) is of additional value in the diagnostic work-up…”
Get full text

Presence of the anti-Jo-1 autoantibody excludes inclusion body myositis by Hengstman, G J, van Engelen, B G, Badrising, U A, van den Hoogen, F H, van Venrooij, W J

Get more information

TREX1 mutations are not associated with sporadic inclusion body myositis by Cox, F. M., Boon, E. M. J., Van Der Lans, C. A. C., Bakker, E., Verschuuren, J. J. G. M., Badrising, U. A.

“…Background:  Sporadic inclusion body myositis (sIBM) is the most frequent acquired myopathy above the age of fifty. The exact mechanism causing this disease is…”
Get full text

Dysphagia in ambulant patients with Parkinson's disease: common, not dangerous by Wintzen, A R, Badrising, U A, Roos, R A, Vielvoye, J, Liauw, L, Pauwels, E K

“…To assess the frequency of subjective and objective dysphagia and its possible pulmonary sequelae, we prospectively studied 22 out-patients with Parkinson's…”
Get more information

Regional variation of Guillain-Barré syndrome by Doets, Alex Y, Verboon, Christine, van den Berg, Bianca, Harbo, Thomas, Cornblath, David R, Willison, Hugh J, Islam, Zhahirul, Attarian, Shahram, Barroso, Fabio A, Bateman, Kathleen, Benedetti, Luana, van den Bergh, Peter, Casasnovas, Carlos, Cavaletti, Guido, Chavada, Govindsinh, Claeys, Kristl G, Dardiotis, Efthimios, Davidson, Amy, van Doorn, Pieter A, Feasby, Tom E, Galassi, Giuliana, Gorson, Kenneth C, Hartung, Hans-Peter, Hsieh, Sung-Tsang, Hughes, Richard A C, Illa, Isabel, Islam, Badrul, Kusunoki, Susumu, Kuwabara, Satoshi, Lehmann, Helmar C, Miller, James A L, Mohammad, Quazi Deen, Monges, Soledad, Nobile Orazio, Eduardo, Pardo, Julio, Pereon, Yann, Rinaldi, Simon, Querol, Luis, Reddel, Stephen W, Reisin, Ricardo C, Shahrizaila, Nortina, Sindrup, Soren H, Waqar, Waheed, Jacobs, Bart C

“…Reports from single countries suggest regional differences in Guillain-Barré syndrome (GBS), but no comparative studies have been conducted. Doets et al…”
Get full text

Influence of bolus volume on hyoid movements in normal individuals and patients with Parkinson's disease by Wintzen, A R, Badrising, U A, Roos, R A, Vielvoye, J, Liauw, L

“…The swallowing movements of 22 ambulant patients with Parkinson's disease were examined by videofluoroscopy, 15 spouses serving as controls. The relation…”
Get more information

Current treatment practice of Guillain-Barré syndrome by Verboon, Christine, Doets, Alex Y, Galassi, Giuliana, Davidson, Amy, Waheed, Waqar, Péréon, Yann, Shahrizaila, Nortina, Kusunoki, Susumu, Lehmann, Helmar C, Harbo, Thomas, Monges, Soledad, Van den Bergh, Peter, Willison, Hugh J, Cornblath, David R, Jacobs, Bart C

“…OBJECTIVETo define the current treatment practice of Guillain-Barré syndrome (GBS). METHODSThe study was based on prospective observational data from the first…”
Get full text

Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis by van der Meulen, Marjon F.G, Hoogendijk, Jessica E, Moons, Karl G.M, Veldman, Henk, Badrising, Umesh A, Wokke, John H.J

“…Problems in diagnosing sporadic inclusion body myositis may arise if all clinical features fit a diagnosis of polymyositis, but the muscle biopsy shows some…”
Get full text

Second IVIg course in Guillain‐Barré syndrome patients with poor prognosis (SID‐GBS trial): Protocol for a double‐blind randomized, placebo‐controlled clinical trial by Walgaard, Christa, Jacobs, Bart C., Lingsma, Hester F., Steyerberg, Ewout W., Cornblath, David R., van Doorn, Pieter A., van Doorn, P.A., Jacobs, B.C., Walgaard, C., de Wit, M.C.Y., Steyerberg, E.W., Cornblath, D.R., van den Berg, B., Doets, A.Y., van Doorn, P.A., Jacobs, B.C., Leonhard, S.E., Verboon, J.C., Walgaard, C., van Woerkom, M., Tio‐Gillen, A.P., van Rijs, W., Huizinga, H., Badrising, U.A., Bienfait, H.M.E., Blom, R.J., van Boheemen, C.J.M., Breukelman, A.J., Bronner, I.M., Dieks, H.J.G., van Dijk, G.W., van Engelen, B.G.M., Faber, C.G., Feenstra, B., Fokke, C., Garssen, M.P.J., Gijsbers, C.J., Gilhuis, H. J., van der Graaff, M.M., Groen, R.J., Hoogendoorn, T.A., Hovestad, A., Jansen, P.J.H.W., Jellema, K., Keuter, E., Kleyweg, R.P., van Koningsveld, R., van der Kooi, A.J., van der Kooi, E.L., Krudde, J., Kuks, J.B.M., Kuitwaard, K., Linssen, W.H.J.P., Lion, J., Lovenich, H., Manschot, S.M., Mellema, S.J., Merkies, I.S.J., van der Meulen, M.F.G., van der Meulen, W.D.M., Molenaar, D.S.M., Oenema, D.G., van Oosten, B.W., van Oostrom, J.C.H., van Orshoven, N.P., van der Ploeg, R.J.O, van der Pol, W.L., Polman, S., van der Ree, T.C., de Rijk, M.C., Ruitenberg, A., Ruts, L., Samijn, J.P.A., Schyns‐Soeterboek, A.J.G.M., Stevens, M., Vermeij, F.H., Verschuuren, J.J.G.M., Visser, L.H., Wirtz, P.W., Wohlgemuth, M., Zwetsloot, C.P., Lingsma, H.F., Steyerberg, E.W., Dippel, D.W.J., Hintzen, R.Q.

“…One course of intravenous immunoglobulins (IVIg) of 2 g/kg is standard treatment in Guillain‐Barré syndrome (GBS) patients unable to walk independently…”
Get full text

1st FSHD European Trial Network workshop:Working towards trial readiness across Europe by Voermans, N.C., Vriens-Munoz Bravo, M., Padberg, G.W., Laforêt, P., van Alfen, N., Attarian, S., Badrising, U.A., Bugiardini, E., González, P. Camano, Carlier, R.Y., Desguerre, I., Diaz-Manera, J., Dumonceaux, J., van Engelen, B.G., Evangelista, T., Khosla, S., de Munain, A. López, van der Maarel, S.M., Mejat, A., Monforte, M., Montagnese, F., Mul, K., Oflazer, P., Porter, B., Quijano-Roy, S., Ricci, E., Sacconi, S., Sansone, V.A., Schoser, B., Statland, J., Stumpe, E., Tasca, G., Tawil, R., Turner, C., Vissing, J.

“…•The FSHD European Trial Network (FSHD ETN) will have an open membership.•There will be four working groups (WG) on clinical and genetic diagnosis (WG 1),…”
Get full text

259th ENMC international workshop: Anaesthesia and neuromuscular disorders 11 December, 2020 and 28–29 May, 2021 by van den Bersselaar, LR, Riazi, S, Snoeck, MMJ, Jungbluth, H, Voermans, NC, Bastian, Börge, van den Bersselaar, Luuk R., Cornel, Martina, Cambronero, Oscar Díaz, Dietrich, Klaus, van Esch, Charlotte, Forzano, Francesca, Gillies, Robyn, Hellblom, Anna, Heytens, Luc, Hopkins, Phil, Johannsen, Stephan, Jungbluth, Heinz, Kamsteeg, Erik-Jan, Klein, Andrea, Litman, Ron, Løkken, Nicoline, Münster, Tino, Reimann, Jens, Rendu, John, Riazi, Sheila, Rueffert, Henrik, Silva, Helga CA, Snoeck, Marc MJ, Soller, Maria, Stowell, Kathryn, Tasca, Giorgio, Veyckemans, Francis, Vilchez, Juan Jesus, Voermans, Nicol C.

“…•An overview of current knowledge on anaesthesia and neuromuscular disorders was presented.•A multidisciplinary approach is essential for optimal…”
Get full text

Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases by Herbert, Megan K, Stammen-Vogelzangs, Judith, Verbeek, Marcel M, Rietveld, Anke, Lundberg, Ingrid E, Chinoy, Hector, Lamb, Janine A, Cooper, Robert G, Roberts, Mark, Badrising, Umesh A, De Bleecker, Jan L, Machado, Pedro M, Hanna, Michael G, Plestilova, Lenka, Vencovsky, Jiri, van Engelen, Baziel G, Pruijn, Ger J M

“…The diagnosis of inclusion body myositis (IBM) can be challenging as it can be difficult to clinically distinguish from other forms of myositis, particularly…”
Get more information

Autoantibodies to cytosolic 5′-nucleotidase 1A in inclusion body myositis by Pluk, Helma, van Hoeve, Bas J. A., van Dooren, Sander H. J., Stammen-Vogelzangs, Judith, van der Heijden, Annemarie, Schelhaas, Helenius J., Verbeek, Marcel M., Badrising, Umesh A., Arnardottir, Snjolaug, Gheorghe, Karina, Lundberg, Ingrid E., Boelens, Wilbert C., van Engelen, Baziel G., Pruijn, Ger J. M.

“…Objective Sporadic inclusion body myositis (sIBM) is an inflammatory myopathy characterized by both degenerative and autoimmune features. In contrast to other…”
Get full text

'Inclusion body'-myositis by Badrising, U A, Maat-Schieman, M L, van Duinen, S G, van Dijk, J G, Verschuuren, J J, Wintzen, A R

“…In 3 patients, a 72-year-old man, a 62-year-old man and a 73-year-old woman with weakness of respectively the quadriceps femoris, the finger flexors and the…”
Get more information

Association of the leukocyte immunoglobulin G (Fcγ) receptor IIIa-158V/F polymorphism with inflammatory myopathies in Dutch patients by Bronner, I. M., Hoogendijk, J. E., De Visser, M., Van De Vlekkert, J., Badrising, U. A., Wintzen, A. R., Uitdehaag, B. M. J., Blokland-Fromme, M., Leusen, J. H. W., Van Der Pol, W.-L.

“…Leukocytes are involved in the pathogenesis of idiopathic inflammatory myopathies (IIMs). Immunoglobulin G (IgG) receptors (FcγR) link the specificity of IgG…”
Get full text